» Articles » PMID: 9496937

Abnormal Intestinal Intraepithelial Lymphocytes in Refractory Sprue

Overview
Specialty Gastroenterology
Date 1998 Mar 13
PMID 9496937
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: The etiology of refractory sprue is unclear. To gain insight into its pathogenesis, the phenotype and T-cell receptor (TCR) gene rearrangement status of intestinal lymphocytes were analyzed in a group of patients with clinical or biological features of celiac disease but either initially or subsequently refractory to a gluten-free diet.

Methods: Intestinal biopsy specimens were obtained from 26 adults: 6 patients with refractory sprue, 7 patients with active celiac disease, and 13 normal controls. The phenotype of intestinal lymphocytes was studied by immunohistochemistry and, in 3 patients with refractory sprue, by cytometry of lymphocytes purified from intestinal biopsy specimens. TCR rearrangements were assessed by studying TCRgammaV-J junctional regions from DNA extracted from intestinal biopsy specimens and purified intestinal lymphocytes.

Results: In the 6 patients with refractory sprue, but not in normal controls or patients with active celiac disease, the intestinal epithelium was massively infiltrated by small lymphocytes that lacked CD8, CD4, and TCR, contained intracytoplasmic but not surface CD3epsilon chains, and exhibited restricted TCRgamma gene rearrangements.

Conclusions: Refractory sprue is associated with an abnormal subset of intraepithelial lymphocytes containing CD3epsilon and restricted rearrangements of the TCRgamma chain but lacking surface expression of T-cell receptors.

Citing Articles

Refractory Celiac Disease: What the Gastroenterologist Should Know.

Verdelho Machado M Int J Mol Sci. 2024; 25(19).

PMID: 39408713 PMC: 11477276. DOI: 10.3390/ijms251910383.


Intraepithelial Lymphocytes of the Intestine.

Lockhart A, Mucida D, Bilate A Annu Rev Immunol. 2024; 42(1):289-316.

PMID: 38277691 PMC: 11608099. DOI: 10.1146/annurev-immunol-090222-100246.


Guidelines for best practices in monitoring established coeliac disease in adult patients.

Elli L, Leffler D, Cellier C, Lebwohl B, Ciacci C, Schumann M Nat Rev Gastroenterol Hepatol. 2023; 21(3):198-215.

PMID: 38110546 DOI: 10.1038/s41575-023-00872-2.


Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges.

Scarmozzino F, Pizzi M, Pelizzaro F, Angerilli V, Dei Tos A, Piazza F Front Oncol. 2023; 13:1273305.

PMID: 38023263 PMC: 10662059. DOI: 10.3389/fonc.2023.1273305.


Immunopathogenesis and environmental triggers in coeliac disease.

Levescot A, Malamut G, Cerf-Bensussan N Gut. 2022; .

PMID: 35879049 PMC: 9554150. DOI: 10.1136/gutjnl-2021-326257.